Climbing mountain with MacTrigger: DDS technologies to treat cancer

January 25, 2026Drug Delivery SystemOpen Access

View Full Paper

Ask AI

Bookmark

Share

Key Points

The aim is to develop a novel treatment method utilizing genetically modified macrophages to combat cancer.
Developed gene-modified macrophages named MacTrigger that release TNF-α upon accumulating in cancer tissue.
Administered MacTrigger intravenously to induce strong acute inflammation in tumors.
Analyzed the shift of tumors into inflammatory environments, enhancing immune response against cancer.
MacTrigger successfully transformed tumor environments into inflammatory tissues, facilitating immune attack against cancer.
Efficacy marked by induction of TNF-α release led to enhanced activation of NK cells and cytotoxic T cells against tumor cells.

Demonstrates cancer treatment efficacy using MacTrigger in tumor environments, indicating a novel therapeutic approach.

No abstract yet. The journal hasn't published one we can show.

No takes yet. Share an insight, caveat, or question.

Teruki Nii (2026) studied this question.

View Full Paper

Ask AI

Bookmark

Share